Glucagon
7 NDCs across 5 manufacturers|4 Generic,3 Brand
Glucagon is used to treat anaphylaxis, bradycardia, hypoglycemia, hypotension and cardiogenic shock, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 11, 1998, and the first generic was approved Dec 28, 2020. In 2024, Medicare Part D spent $111 million on Glucagon across 237,000 claims for 162,000 beneficiaries.
Glucagon is available as 7 NDCs from 5 manufacturers (4 generic, 3 brand), with NADAC prices from $128.14 to $293.23 per EA — the most expensive product costs about 2.3× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
7
4G / 3B
Manufacturers
5
competing in market
Price Spread
$128.14 – $293.23
per EA
7d Activity
avg -2.0% WoW · of 7 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Weekly brief
Referenced in the latest weekly brief
This market appears in the current weekly executive summary or among the latest featured movers.
Top supplier
Amphastar Pharmaceuticals, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antihypoglycemic Agent class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing GLUCAGON
| Watch | Drug ↕ | Price | 7d Change ↕ |
|---|---|---|---|
BAQSIMI 3 MG SPRAY TWO PACK | $293.2273 per EA | +0.04% | |
BAQSIMI 3 MG SPRAY ONE PACK | $293.1565 per EA | +0.07% | |
GLUCAGON 1 MG EMERGENCY KIT | $238.3043 per EA | +0.54% | |
GLUCAGON 1 MG EMERGENCY KIT | $128.1424 per EA | -4.70% | |
GLUCAGON 1 MG EMERGENCY KIT | $128.1424 per EA | -4.70% | |
GLUCAGON 1 MG EMERGENCY KIT | $128.1424 per EA | -4.70% | |
GLUCAGON 1 MG EMERGENCY KIT | $128.1424 per EA | -4.70% |
Frequently Asked Questions
What is Glucagon used to treat?
Glucagon is used to treat anaphylaxis, bradycardia, hypoglycemia, hypotension and cardiogenic shock, per the National Library of Medicine's MED-RT classification.
When did Glucagon become available as a generic?
FDA approved the first generic Glucagon (ANDA) on Dec 28, 2020.
How much does Medicare spend on Glucagon?
In 2024, Medicare Part D spent $111 million on Glucagon across 237,000 claims for 162,000 beneficiaries.
How many Glucagon products are on the market?
The Glucagon drug market contains 7 NDCs from 5 manufacturers — 4 generic and 3 brand products.
What is the price range for Glucagon?
NADAC reference prices for Glucagon range from $128.1424 to $293.2273 per EA — the most expensive product costs about 2.3× the cheapest.
Is generic Glucagon cheaper than brand?
The average generic NADAC for Glucagon is $128.1424 per EA, versus $274.8961 for brand-labeled products — brand versions average about 2.1× the generic price.
Which manufacturers make Glucagon?
5 manufacturers list Glucagon in NADAC. Ranked by number of NDCs, the largest are Amphastar Pharmaceuticals, Inc. (3), Fresenius Kabi USA, LLC (1), Mylan Pharmaceuticals Inc. (1), Cipla USA Inc. (1), Lupin Pharmaceuticals Inc. (1).
How has the price of Glucagon changed recently?
Over the past 7 days, 5 Glucagon NDCs rose and 4 fell, with a market-wide average change of -2.0%.